Costly, chronic and complicated: New report sheds light on challenges of life with type 1 diabetes
- First report of its kind in a decade shows the incidence of type one diabetes (T1D) in Australia has grown to more than 125,000 people today, with the economic cost now standing at a staggering $2.9 billion per year.
- The report also highlights the significant financial impact of complications of the disease, with the presence of just two complications increasing the cost to the economy more than fourfold.
- There is also a serious mental health impact of living with T1D, with patients five times more likely to experience depression and almost twice as likely to experience anxiety.
- There is hope, as access to life-saving technologies and new treatments can reduce costs by 14% and improve quality of life.
1 JUNE 2021, SYDNEY: Today, a report released by JDRF Australia has highlighted the economic, physical and mental toll delivered by T1D. This first new report of its type in more than ten years systematically reviews the implications of T1D and uncovers a condition that is growing, costing more and placing an undue burden on individual patients. Yet there is also hope, with the report showing the potential impact increasing access to technologies critical to effective care, namely devices such as pumps or continuous glucose meters, can have on the patient’s physical and financial health.
The report, commissioned by JDRF and conducted by Accenture, found that T1D is growing and will continue to do so, with an estimated further 25,000 individuals having early stages of T1D but not yet clinically diagnosed. In addition, half of all new diagnoses are children aged 0-19, meaning a lifetime living with the condition.
In addition to the lifelong clinical challenges such a diagnosis creates, there are significant financial issues. Even without complications, living with T1D costs the economy $9,000 a year. Add in a complication (40% of people with T1D have at least one) the cost jumps to $32,000 annually – rising to $49,000 for three or more complications.
Commenting on the findings, CEO of JDRF Australia Mike Wilson OAM states that this can’t be allowed continue: “It’s simply not acceptable that the economy spends the equivalent of the cost of a new car every year just to keep some Australians alive. We have made some great advances in our understanding of T1D and ways to minimise its impact in recent years. We must continue to strive to ensure more patients have access to the standard of care and continue to find new and innovative ways to fight T1D.”
The report supports the view that increased access to T1D technology has both economic and medical advantages. Access to continuous glucose monitors (CGMs) and insulin pumps can help people with T1D manage their glucose levels, reducing the risk of complications. The current cost of these technologies, at around $6,500 a year together (~$2,500 for an insulin pump and pump consumables, and ~$4,000 for a CGM), is out of reach for many patients, but the report shows providing more Australians with access to this effective treatment would deliver a benefit that outweighs the cost – reducing average lifetime costs by 14%.
Expanding the access to those young Australians entering the workforce in their 20s, for example, could achieve a net economic benefit of $312m, reducing hospitalisations and other costs, such as impacts on productivity. Healthy years lost due to living with T1D and its complications costs the Australian economy a combined $900 million annually.
Mr Wilson goes on to state that for a complex disease, the potential solutions are straightforward. “T1D is an incredibly complex disease, and there is much about it we are still learning. Yet for today’s patients, there is a simple truth, increasing access to technology will improve health outcomes and reduce financial burden for patients, their families and broader society. We hope this report will spur debate about technology and eventually help drive increased levels of access.”Learn more about the economic costs of T1D
We did it! $2M for type 1 diabetes research
This year, we asked you a question: could you be the 1? Could you be the 1 who… Helps change the lives of more than 125,000 Australians? Makes an investment in a future without T1D, one which pays life-changing dividends? Moves the needle in 2021? And you answered the call. Thank you for coming together as 1 community to bring about […]
JDRF supporter and leading researcher recognised with Order of Australia
Today, we are excited to announce that two important members of the JDRF community have been appointed members of the Order of Australia as part of the Queen’s Birthday 2021 Honours List. Helen Maxwell-Wright We’re proud to be celebrating Helen Maxwell-Wright, Chair of our Victorian State Leadership Group and major supporter of type 1 diabetes […]
Aussies urged to dig deep in support of research to reduce mental health strain on those with type 1 diabetes
Australians living with type one diabetes (T1D) are disproportionately affected by a psychological phenomenon called decision fatigue, which hinders their ability to make vital decisions – placing them at greater risk of life-threatening complications such as heart attack and kidney disease.1 People living with T1D must make an extra 180 decisions every day compared to […]